Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Review
Drugs
2025
Acoltremon: First Approval.
Arnold Lee
PubMed ↗
Publisher ↗
No numbers read from the abstract.
2 papers cite it
2025
2026
this paper
cites it
The trial
NCT07502378
phase 4
50 enrolled
2026
Acoltremon: First Approval. | OpenQuestion